Kelly Blackburn - Jan 26, 2024 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role
SVP, Clinical Development
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Stock symbol
CRVO
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 06:46 PM
Previous filing
Sep 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVO Stock Option (Right to Buy) Award $0 +16K $0.00 16K Jan 26, 2024 Common Stock 16K $9.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024.